caBIG« and The Netherlands
Headquartered in The Netherlands, the Center for Translational Molecular Medicine (CTMM) is dedicated to the development of medical technologies that enable the design of new and "personalized" treatments.
Within the CTMM's DeCoDe (Decrease Colorectal cancer Death) consortium, representatives from five academic institutions and eight industry organizations are working together to develop new approaches to diagnose colorectal cancer early and accurately.
About the Partnership
CTMM has implemented OpenClinica, caTissue, caArray, and caIntegrator to support data sharing and exchange within the DeCoDe consortium. The CTMM is also developing a plan that outlines opportunities to implement additional caBIG« applications across the center.